(Q24234480)

https://api.crossref.org/works/10.1002%2F14651858.CD008347.PUB2

Sarpogrelate hydrochloride, a selective 5-hydroxytryptamine(2A) antagonist, augments autologous bone marrow mononuclear cell implantation-induced improvement in endothelium-dependent vasodilation in patients with critical limb ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008347.PUB2

Treatment of non-healing skin ulcers with autologous activated mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008347.PUB2

Beneficial effects of autologous bone marrow cell infusion and antioxidants/L-arginine in patients with chronic critical limb ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008347.PUB2

Rationale and design of the JUVENTAS trial for repeated intra-arterial infusion of autologous bone marrow-derived mononuclear cells in patients with critical limb ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008347.PUB2

Transplantation of autologous mononuclear bone marrow stem cells in patients with peripheral arterial disease (the TAM-PAD study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008347.PUB2

Bone marrow-derived mononuclear cell therapy induces distal angiogenesis after local injection in critical leg ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008347.PUB2

Autologous bone-marrow mononuclear cell implantation improves endothelium-dependent vasodilation in patients with limb ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008347.PUB2

ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascul

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008347.PUB2

Autologous transplantation of granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells improves critical limb ischemia in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008347.PUB2

Marrow stromal cells as stem cells for nonhematopoietic tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008347.PUB2

Augmentation of postnatal neovascularization with autologous bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008347.PUB2

Macrophage-induced angiogenesis is mediated by tumour necrosis factor-α

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008347.PUB2

Long-term clinical outcome after intramuscular implantation of bone marrow mononuclear cells (Therapeutic Angiogenesis by Cell Transplantation [TACT] trial) in patients with chronic limb ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008347.PUB2

7 January 2021

Bone marrow mobilization with granulocyte macrophage colony-stimulating factor improves endothelial dysfunction and exercise capacity in patients with peripheral arterial disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008347.PUB2

7 January 2021

Autologous bone-marrow mononuclear cell implantation in patients with severe lower limb ischaemia: a comparison of using blood cell separator and Ficoll density gradient centrifugation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008347.PUB2

7 January 2021

Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008347.PUB2

7 January 2021

Design and rationale of a randomized, double-blind, placebo-controlled phase III study for autologous bone marrow cell transplantation in critical limb ischemia: the BONe Marrow Outcomes Trial in Critical Limb Ischemia (BONMOT-CLI)

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008347.PUB2

7 January 2021

Long-term effects of repeated autologous transplantation of bone marrow cells in patients affected by peripheral arterial disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008347.PUB2

7 January 2021

Autologous transplantation of peripheral blood stem cells as an effective therapeutic approach for severe arteriosclerosis obliterans of lower extremities

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008347.PUB2

7 January 2021

Randomised comparison of G-CSF-mobilized peripheral blood mononuclear cells versus bone marrow-mononuclear cells for the treatment of patients with lower limb arteriosclerosis obliterans.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008347.PUB2

7 January 2021

Granulocyte colony-stimulating factor: a noninvasive regeneration therapy for treating atherosclerotic peripheral artery disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008347.PUB2

7 January 2021